Cellebrite DI Ltd (NAS:CLBT)
$ 16.27 -0.24 (-1.45%) Market Cap: 4.06 Bil Enterprise Value: 3.65 Bil PE Ratio: 58.11 PB Ratio: 7.94 GF Score: 83/100

Cellebrite DI Ltd at Morgan Stanley Technology, Media & Telecom Conference Transcript

Mar 03, 2026 / 03:45PM GMT
Release Date Price: $13.75 (+1.81%)
Melissa Knox
Morgan Stanley - Analyst

All right. Welcome. Good morning, everyone. I'm Melissa Knox. I run the Global Software Banking business here at Morgan Stanley.

And I am extremely excited to be here with Dave Barter, CFO of Cellebrite. Cellebrite is a leader in digital investigative solutions to state and local governments, federal agencies, enterprises and has had a tremendous run. So we'll talk about how the stock has performed, where you are today, some of the new solutions that you have out leveraging AI and data.

Questions & Answers

Melissa Knox
Morgan Stanley - Analyst

First, Dave, just give us an overview on the products that Cellebrite sells. There are 3 of them, 3 kind of main products, but why don't you go into what you're selling on the Case-to-Closure platform, starting with digital forensic software, your Inseyets product.

David Barter
Cellebrite DI Ltd - Chief Financial Officer

Super, and good morning, and thank you so much for having us here today. This is always great to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot